Detalhe da pesquisa
1.
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Blood
; 139(12): 1908-1919, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914826
2.
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
N Engl J Med
; 382(6): 545-553, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32023374
3.
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells.
Blood
; 137(5): 624-636, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32902645
4.
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.
Sci Adv
; 9(30): eadd6997, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494448
5.
A phase two study of high dose blinatumomab in Richter's syndrome.
Leukemia
; 36(9): 2228-2232, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941212
6.
Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia.
Front Immunol
; 13: 1018047, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36203567
7.
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies.
Clin Cancer Res
; 27(13): 3744-3756, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33986022
8.
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD.
Front Immunol
; 12: 631353, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017325
9.
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells.
Blood Adv
; 4(14): 3357-3367, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32717029